Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
Jason Behary, Nadia Amorim, Xiaotao Jiang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 299

Showing 26-50 of 299 citing articles:

Gut–liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice
Xueliang Wang, Yi Fang, Wei Liang, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 4
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Hui Han, Yi Jiang, Mengyu Wang, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 12, pp. 1689-1706
Closed Access | Times Cited: 87
NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
Matthias Pinter, David J. Pinato, Pierluigi Ramadori, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 3, pp. 513-520
Open Access | Times Cited: 58
Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury
Hesuiyuan Wang, Qing Wang, Chengmao Yang, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Elke Roeb, Ali Canbay, Frank Tacke, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. 1346-1421
Open Access | Times Cited: 51
An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysis
Jiaheng Xie, Liang Chen, Qingmei Sun, et al.
Aging (2022) Vol. 14, Iss. 7, pp. 3276-3292
Open Access | Times Cited: 48
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response
Yue Shen, Shengdi Wu, Yao Chen, et al.
Gut Microbes (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 43
Phenolics from noni (Morinda citrifolia L.) fruit alleviate obesity in high fat diet-fed mice via modulating the gut microbiota and mitigating intestinal damage
Ruimin Wang, Lu Wang, Shengwei Wang, et al.
Food Chemistry (2022) Vol. 402, pp. 134232-134232
Closed Access | Times Cited: 40
Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
Tingyu Fang, Hua Wang, Xiaoyue Pan, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5681-5697
Open Access | Times Cited: 38
Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
Maria Kotsari, Vassiliki Dimopoulou, John Koskinas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11471-11471
Open Access | Times Cited: 36
The polysaccharides from Auricularia auricula alleviate non-alcoholic fatty liver disease via modulating gut microbiota and bile acids metabolism
Yifan Shu, Yujie Huang, Wei Dong, et al.
International Journal of Biological Macromolecules (2023) Vol. 246, pp. 125662-125662
Closed Access | Times Cited: 33
The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer
Yuqing Zou, Shuling Wang, Honghua Zhang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 539-567
Closed Access | Times Cited: 33
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2761-2761
Open Access | Times Cited: 33
Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma
Lilong Zhang, Chen Chen, Dongqi Chai, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 31
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions
Jayashi Rajapakse, Saroj Khatiwada, Anna Camille Akon, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 31
Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
Fengna Yan, Qun Zhang, Ke Shi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 28
Research Progress of Fecal Microbiota Transplantation in Liver Diseases
Yuanyuan Zhao, Gong Chen, Jing Xu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1683-1683
Open Access | Times Cited: 26
Statistical normalization methods in microbiome data with application to microbiome cancer research
Yinglin Xia
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 26
MAFLD: an optimal framework for understanding liver cancer phenotypes
Harry Crane, Cameron Gofton, Ankur Sharma, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 10, pp. 947-964
Open Access | Times Cited: 23
Potential links between the microbiota and T cell immunity determine the tumor cell fate
Amir Hossein Mohseni, Sedigheh Taghinezhad‐S, Vincenzo Casolaro, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 22
Integrative multi-omics approaches to explore immune cell functions: Challenges and opportunities
Xu Wang, Fan Dian, Yuqing Yang, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106359-106359
Open Access | Times Cited: 22
Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma
Thananya Jinato, Songtham Anuntakarun, Nantawat Satthawiwat, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 12
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease
Mira Thing, Mikkel Werge, Nina Kimer, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 12
Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
Yumin Wang, Joshua S. Fleishman, Tongda Li, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11
Antitumor immunostimulatory activity of the traditional Chinese medicine polysaccharide on hepatocellular carcinoma
Yang Liu, Jiawen Wu, Huiqin Hao
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11

Scroll to top